Results 151 to 160 of about 2,143 (224)

European Guideline on Chronic Nausea and Vomiting—A UEG and ESNM Consensus for Clinical Management

open access: yesUnited European Gastroenterology Journal, Volume 13, Issue 3, Page 427-471, April 2025.
ABSTRACT Introduction Chronic nausea and vomiting are symptoms of a wide range of gastrointestinal and non‐gastrointestinal conditions. Diagnosis can be challenging and requires a systematic and well‐structured approach. If the initial investigation for structural, toxic and metabolic disorders is negative, digestive motility and gut‐brain interaction ...
Carolina Malagelada   +34 more
wiley   +1 more source

Medication review interventions for adults living with advanced chronic kidney disease: A scoping review

open access: yesBritish Journal of Clinical Pharmacology, Volume 91, Issue 4, Page 1132-1156, April 2025.
Abstract Structured medication reviews (SMRs) were introduced into the National Health Service (NHS) Primary Care to support the delivery of the NHS Long‐Term Plan for medicines optimization. SMRs improve the quality of care, reduce harm and offer value for money. However, evidence to support SMRs for patients with chronic kidney disease (CKD) stage G4‐
Cathy Margaret Pogson   +3 more
wiley   +1 more source

Ex vivo receptor occupation of GTS-21, a novel nicotinic receptor agonist, in rats.

open access: gold, 1996
Yoshihisa Nozawa   +4 more
openalex   +1 more source

Advances in PET Imaging of α7 Nicotinic Receptors: From Radioligand Development to CNS Applications

open access: yesBasic &Clinical Pharmacology &Toxicology, Volume 136, Issue 4, April 2025.
ABSTRACT Positron emission tomography (PET) has significantly advanced our understanding of the brain by enabling non‐invasive imaging and quantification of molecular processes, including receptor binding. In this review, we explore the development and application of PET radioligands targeting the α7 nicotinic acetylcholine receptor (α7 nAChR), a ...
Janus H. Magnussen
wiley   +1 more source

Ghrelin: An Emerging Therapy for Heart Failure

open access: yesClinical Endocrinology, Volume 102, Issue 4, Page 403-412, April 2025.
ABSTRACT Objective Ghrelin is emerging as a promising therapeutic option for heart failure (HF) due to its potent inotropic, anabolic, and cardioprotective properties. This review aims to critically examine the available clinical evidence on ghrelin therapy in HF, while also incorporating key findings from preclinical studies that support its ...
Nikolaos Theodorakis   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy